Scientific research reveals how workplace environments and occupational factors influence breast cancer risk through chemical exposures, psychosocial stress, and sedentary behavior.
Explore how computational methods are revolutionizing breast cancer treatment through identification of non-steroidal aromatase inhibitors.
Exploring the complex barriers preventing breast cancer patients from adhering to adjuvant endocrine therapy and promising solutions to improve treatment outcomes.
Exploring the impact of breast cancer therapies on fertility and the latest scientific advancements offering hope to young survivors.
Explore how preoperative systemic therapy is transforming breast cancer treatment through tumor downsizing, personalized response testing, and improved surgical outcomes.
Learn about the promising CAPItello-292 trial testing a triple-combination therapy for HR+/HER2- advanced breast cancer that targets multiple cancer pathways simultaneously.
Discover how the synergistic combination of letrozole and panobinostat provides a powerful new approach to treating hormone-positive breast cancer through dual suppression of aromatase.
Discover how triple hormone receptor signatures are revolutionizing breast cancer classification and prognosis through cell-of-origin biology.
How localized hormone therapy with vaginal testosterone offers new hope for women facing intimate health challenges after breast cancer treatment.
Discover how mathematical modeling reveals the hidden relationship between mTOR and NMT proteins in breast cancer, offering new insights into treatment resistance.